Hepatitis C - alpha interferon and ribavirin (TA14) (replaced by TA75)
The clinical and cost effectiveness of pegylated interferon alpha 2a and alpha 2b for hepatitis C
This guidance has been replaced by TA75 Hepatitis C - pegylated interferons, ribavirin and alfa interferon
This page was last updated: 20 December 2011
Implementation tools and resources
- None available
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.